Clopidogrel Bisulphate API
IOL Chemicals and Pharmaceuticals Limited Expertise in producing Clopidogrel Bisulfate API
IOLCP, a prime API manufacturer & supplier, produces Clopidogrel Bisulfate API with a fully backward integrated process & in a dedicated facility.
The process ensures the production of pharmaceutically acceptable polymorphic form II.
Our production of Clopidogrel Bisulfate API follows the highest quality standards that meet all Pharmacopeial and ICH requirements.
A well-controlled strategy has been put in place for all Tosylate esters which are known to be potential mutagenic impurities to ensure the highest quality of Clopidogrel Bisulfate API.
Contact Us
Contact Us
IOL Chemicals and Pharmaceuticals Limited Expertise in producing Clopidogrel Bisulfate API
IOLCP, a prime API manufacturer & supplier, produces Clopidogrel Bisulfate API with a fully backward integrated process & in a dedicated facility.
The process ensures the production of pharmaceutically acceptable polymorphic form II.
Our production of Clopidogrel Bisulfate API follows the highest quality standards that meet all Pharmacopeial and ICH requirements.
A well-controlled strategy has been put in place for all Tosylate esters which are known to be potential mutagenic impurities to ensure the highest quality of Clopidogrel Bisulfate API.
Mechanism of Action
Clopidogrel Bisulfate API is metabolized to its active form by carboxylesterase-1 and the active metabolite of Clopidogrel selectively inhibits the binding of adenosine diphosphate (ADP) to its platelet P2Y12 receptor and the subsequent ADP- mediated activation of the glycoprotein GPIIb/IIIa complex, thereby inhibiting platelet aggregation.
Indication
The main therapeutic indications of Clopidogrel Bisulfate API are:
This API is an important medicine used in cardiovascular therapies.
Clopidogrel bisulphate, an active pharmaceutical ingredient, is an antiplatelet drug and helps keep blood flowing smoothly in your body.
This API also helps in preventing future heart attacks, strokes, and other clot-related diseases in patients who have already had a heart attack, stroke, or have certain cardiovascular conditions.
Download Our Brochure to Know More
Related Products
